3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 4
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Hemorrhage
2
Chronic Pain
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Parathyroid Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Interventions
Ketamine
3
Sodium Chloride
2
Ropivacaine
2
Propofol
2
Analgesics, Opioid
2
Analgesia, Patient-Controlled
2
parecoxib
1
Tea
1
Tapentadol
1
Surveys and Questionnaires
1
Sevoflurane
1
Saline Solution
1
Lidocaine
1
Ketorolac
1
Ibuprofen
1
Epinephrine
1
Dexamethasone
1
Codeine
1
Clonidine
1
Circumcision, Male
1
Celecoxib
1
Anesthesia, General
1
Acupuncture Therapy
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Agnosia
×
Sodium Chloride
×
Clear all
NCT02256228
2019-01-15
IPLA
Göteborg University
Phase 3
Completed
40 enrolled
NCT01951911
2017-07-11
KETA-1
Haukeland University Hospital
Phase 3
Withdrawn